Prof. Dr. Ibrahim Benter, Dean of the Faculty of Pharmacy at Final International University, stands out as a leading figure and a scientific school of thought in the international academic community through the profound impact of his research. With more than 7,000 citations to his scientific publications, Prof. Dr. Benter’s work demonstrates not only individual academic excellence but also the global recognition and adoption of the scientific approach he pioneered.

In 1993, Prof. Dr. Benter identified the angiotensin-(1–7) molecule and revealed its significant potential role in the treatment of cardiovascular diseases, particularly through its anti-inflammatory effects. This groundbreaking discovery laid the scientific foundation for subsequent research in numerous fields, including hypertension, diabetes, metabolic disorders, and heart failure. Over the years, Prof. Dr. Benter’s work has evolved into a widely referenced scientific framework, establishing him as an authority and a school of thought in this field.

Today, thousands of scientific publications focus on the angiotensin-(1–7) and ACE2 system, while clinical studies conducted in many countries—particularly in the United States—continue to investigate the molecule’s effects on various diseases. A scientometric study published in 2025 identified Prof. Dr. Ibrahim Benter as the most prolific researcher worldwide in publications related to the ACE2–angiotensin-(1–7) system in the field of diabetes, further highlighting his scientific leadership.

The research conducted under the leadership of Prof. Dr. Ibrahim Benter within the Faculty of Pharmacy at Final International University significantly enhances the university’s international academic visibility and positions both the university and its Faculty of Pharmacy among leading institutions in scientific research and academic productivity.